NIGHTSTAR THERAPEUTICS PLC (NITE) financial statements (2021 and earlier)

Company profile

Business Address C/O NIGHTSTAR, INC.
WALTHAM, MA 02453
State of Incorp.
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments164
Cash and cash equivalents28
Short-term investments136
Receivables1
Prepaid expense5
Other current assets0
Other undisclosed current assets9
Total current assets:179
Noncurrent Assets
Property, plant and equipment1
Other noncurrent assets0
Total noncurrent assets:1
TOTAL ASSETS:180
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8
Accounts payable3
Accrued liabilities2
Employee-related liabilities2
Other undisclosed current liabilities7
Total current liabilities:14
Noncurrent Liabilities
Total liabilities:14
Stockholders' equity
Stockholders' equity attributable to parent166
Common stock0
Additional paid in capital267
Accumulated other comprehensive loss(3)
Accumulated deficit(99)
Total stockholders' equity:166
TOTAL LIABILITIES AND EQUITY:180

Income statement (P&L) ($ in millions)

12/31/2018
Gross profit:7
Operating expenses(44)
Operating loss:(37)
Nonoperating income7
Other nonoperating income4
Loss from continuing operations before equity method investments, income taxes:(31)
Other undisclosed loss from continuing operations before income taxes(7)
Loss from continuing operations before income taxes:(37)
Income tax benefit0
Net loss available to common stockholders, diluted:(37)

Comprehensive Income ($ in millions)

12/31/2018
Net loss:(37)
Comprehensive loss:(37)
Other undisclosed comprehensive loss, net of tax, attributable to parent(5)
Comprehensive loss, net of tax, attributable to parent:(42)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: